Expression of PD-L1 clones (22C3 and 28-8) in hepatocellular carcinoma: a tertiary cancer care hospital experience
Kashif Asghar(Shaukat Khanum Memorial Cancer Hospital and Research Center), Asif Loya(Copenhagen University Hospital)
Cited by 1
Related Papers
A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma
|Scientific Reports|2019|178
Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study
|PLoS ONE|2015|50
Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study
|Hereditary Cancer in Clinical Practice|2019|47
Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan
|Cancer Research and Treatment|2018|22
PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients
|Journal of Hepatocellular Carcinoma|2023|2